Take Your Due
Diligence to a New Level...
value analysis and statistical risk
With dramatic changes in the financial
markets and the rising cost of
bioscience development amounting to hundreds of millions of dollars
invested in each product candidate, there is a pressing need for
unbiased, comprehensive and corroborative due diligence that can guide
private capital and public investment to the strongest life science
opportunities. Parenteau BioConsultants and BioRankings are helping to
address this need with a new brand of due diligence to meet the needs
of life science in 2010 and beyond.
Today's world demands smart choices.
It's time to know more.
BioConsultants & BioRankings Alliance
By combining Parenteau
BioConsultants’ expertise in biological and
immunological science, life science management and concept-to-market
development with BioRankings’ broad expertise in biostatistics that
encompasses many complex medical areas, the Alliance can assess
technical value and risk in a uniquely comprehensive and corroborative
Traditional analyses emphasize time-to-market, market potential and
financials, yet a large part of time-to-market, value creation and risk
is buried in the use and targeting of a technology and a company’s
current ability to manage its execution.
analyzes key factors that will impact the likelihood of generating
commercial value including:
* The likelihood of reaching
therapeutic effectiveness based on science and statistical analysis of
existing data in the space
Lending credence to
time-to-market estimates, market projections and financial estimates
for more confident investment decisions.
* The comparative strength of
a company’s therapeutic target, approach and commercial strategy within
a broad competitive landscape
* The company’s life science
management strategy – pivotal to value creation and competitive position
Wish your life science investments were
less risky and more rewarding? They can be.
Download the free Alliance
Demystified: Investing in High Risk, High Reward Opportunities in
LLC is a biostatistical
consulting service company that
makes complex biostatistical ideas understandable. Founded by Dr.
William Shannon, Associate Professor of Biostatistics in Medicine,
Washington University School of Medicine in St. Louis, BioRankings LLC
brings over 20 years of applied biostatistical expertise in biomedical,
pharmaceutical, and biotech research. In addition to over 80
peer-reviewed publications in diverse areas such as oncology,
pediatrics, genetics, cardiology, pulmonology, infectious disease,
sleep medicine, health care delivery, and many other areas, the
BioRankings LLC staff have advanced technical expertise in
biotechnology, genetics, cell and molecular biology, and technical
writing. Additional information about BioRankings can be found at www.BioRankings.com.